Literature DB >> 25734331

The accuracy of target delineation in laryngeal and hypopharyngeal cancer.

Joana Caldas-Magalhaes1, Nina Kooij, Hans Ligtenberg, Elise A Jager, Tim Schakel, Nicolien Kasperts, Frank A Pameijer, Chris H J Terhaard, Luuk M Janssen, Paul J van Diest, Marielle E P Philippens, Cornelis P J Raaijmakers.   

Abstract

BACKGROUND AND
PURPOSE: To determine the spatial correspondence between the gross tumor volume (GTV) delineated on computer tomography (CT) and the actual tumor on histopathology.
MATERIAL AND METHODS: Sixteen patients with T3 or T4 laryngeal or hypopharyngeal cancer underwent a CT scan before total laryngectomy. The GTV was delineated on CT by three independent observers and by consensus between the three observers. After surgery, whole-mount hematoxylin-eosin stained (H&E) sections were obtained. One pathologist delineated the tumor in the H&E sections (tumorH&E). The reconstructed specimen was registered to the CT scan in order to compare the GTV to the tumorH&E in three dimensions. The overlap between the GTV and the tumorH&E was calculated and the distance between the volumes was determined.
RESULTS: Tumor tissue was delineated in 203 of 516 H&E sections. For 14 patients a detailed analysis could be performed. The GTV volume was on average 1.7 times larger than the volume of the tumorH&E. The mean coverage of the tumorH&E by the consensus GTV was 88%. tumorH&E tissue was found at 1.6 mm to 12.9 mm distance outside the GTV depending on observer and patient.
CONCLUSIONS: GTVs delineated on CT for laryngeal and hypopharyngeal cancer were 1.7 times larger than the tumor. Complete coverage of the tumor by the GTV was, however, not obtained.

Entities:  

Mesh:

Year:  2015        PMID: 25734331     DOI: 10.3109/0284186X.2015.1006401

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  5 in total

1.  CT-based volumetric tumor growth velocity: A novel imaging prognostic indicator in oropharyngeal cancer patients receiving radiotherapy.

Authors:  Subha Perni; Abdallah S R Mohamed; Jacob Scott; Heiko Enderling; Adam S Garden; G Brandon Gunn; David I Rosenthal; Clifton D Fuller
Journal:  Oral Oncol       Date:  2016-11-04       Impact factor: 5.337

2.  Dose accumulation to assess the validity of treatment plans with reduced margins in radiotherapy of head and neck cancer.

Authors:  Nicholas J Lowther; Steven H Marsh; Robert J W Louwe
Journal:  Phys Imaging Radiat Oncol       Date:  2020-06-10

3.  Verification of HE-based CTV in laryngeal and hypopharyngeal cancer using pan-cytokeratin.

Authors:  Hans Ligtenberg; Stefan M Willems; Lilian N Ruiter; Elise Anne Jager; Chris H J Terhaard; Cornelis P J Raaijmakers; Marielle E P Philippens
Journal:  Clin Transl Radiat Oncol       Date:  2018-07-11

4.  Evaluation of diffusion weighted imaging for tumor delineation in head-and-neck radiotherapy by comparison with automatically segmented 18F-fluorodeoxyglucose positron emission tomography.

Authors:  Tim Schakel; Boris Peltenburg; Jan-Willem Dankbaar; Carlos E Cardenas; Michalis Aristophanous; Chris H J Terhaard; Johannes M Hoogduin; Marielle E P Philippens
Journal:  Phys Imaging Radiat Oncol       Date:  2018-01-30

5.  Delineation uncertainties of tumour volumes on MRI of head and neck cancer patients.

Authors:  Ruta Zukauskaite; Christopher N Rumley; Christian R Hansen; Michael G Jameson; Yuvnik Trada; Jørgen Johansen; Niels Gyldenkerne; Jesper G Eriksen; Farhannah Aly; Rasmus L Christensen; Mark Lee; Carsten Brink; Lois Holloway
Journal:  Clin Transl Radiat Oncol       Date:  2022-08-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.